Latanoprost/timolol ophthalmic Interactions
There are 285 drugs known to interact with latanoprost/timolol ophthalmic, along with 14 disease interactions. Of the total drug interactions, 29 are major, 252 are moderate, and 4 are minor.
- View all 285 medications that may interact with latanoprost/timolol ophthalmic
- View latanoprost/timolol ophthalmic disease interactions (14)
Most frequently checked interactions
View interaction reports for latanoprost / timolol ophthalmic and the medicines listed below.
- Aricept (donepezil)
- Aspir 81 (aspirin)
- Azopt (brinzolamide ophthalmic)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Cosopt (dorzolamide / timolol ophthalmic)
- Coumadin (warfarin)
- Crestor (rosuvastatin)
- Eliquis (apixaban)
- Ferrousal (ferrous sulfate)
- Jardiance (empagliflozin)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lantus SoloStar (insulin glargine)
- Lasix (furosemide)
- Lipitor (atorvastatin)
- Lithium Carbonate ER (lithium)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Paracetamol (acetaminophen)
- Simbrinza (brimonidine / brinzolamide ophthalmic)
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Valproate Sodium (valproic acid)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Vitamin K2 (menaquinone)
Latanoprost/timolol ophthalmic disease interactions
There are 14 disease interactions with latanoprost / timolol ophthalmic which include:
- herpes simplex
- asthma/COPD
- bradycardia/AV block
- cardiogenic shock
- CHF
- diabetes
- hypersensitivity
- hyperthyroidism
- PVD
- respiratory disorders
- myasthenia gravis
- macular edema
- uveitis
- renal/liver disease
Report options
QR code containing a link to this page
More about latanoprost / timolol ophthalmic
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.